http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104946592-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate | 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104946592-B |
| titleOfInvention | A kind of Radioresistance lung cancer whole-cell vaccines and its preparation method and application |
| abstract | The present invention relates to a kind of Radioresistance lung cancer whole-cell vaccines and its preparation method and application, specifically, the present invention establishes the Radioresistance lung cancer cell line that a radioresistant significantly improves, preserving number is CCTCC C201537, lung cancer whole-cell vaccines are prepared using the cell line, it confirms that the lung cancer whole-cell vaccines possess by zoopery and significantly inhibits mice lung cancer tumour growth, promote transplanting apoptosis of tumor, reduce the effect of 1 protein expressions of transplantable tumor immunologic escape PDL, it is and more notable with CpG ODN combination tumor-inhibiting actions, and some animals cases of complete remission, obtain lasting specificity antineoplastic effect.The present invention provides new approaches and method for lung cancer therapy and prevention of postoperative transfer and relapse. |
| priorityDate | 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.